pharma
Alzheimer’s protein treatment that works in human cells
April 12, 2018Research and Development Alzheimer's disease, Gladstone Institutes, biotech, drugs, pharma, pharmaceutical
One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …
Sanofi to invest €350m in new Canadian vaccine plant
April 12, 2018Manufacturing and Production Canada, Sanofi, pharma, vaccines
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, …
Bayer contraceptive implant public backlash brings results
April 12, 2018Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
Verona Pharma loses Chief Medical Officer
April 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma
Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
AbbVie’s rheumatoid arthritis drug bests even its own blockbuster Humira at Phase 3
April 11, 2018Research and Development AbbVie, Humira, pharma, rheumatoid arthritis, upadacitinib
AbbVie posted a strong showing this week from its JAK1 inhibitor upadacitinib, indicating that the drug outperformed even its own …
Sobi receives expanded EU approval for Kineret
April 11, 2018Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi
Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …
Pfizer shuts down kidney cancer drug trial due to “futility”
April 11, 2018Research and Development Cancer, Kidney cancer, Pfizer, inlyta, pharma
Pfizer has revealed that it has shut down a trial of its vascular endothelial growth factor (VEGF) inhibitor Inlyta (axitinib) …
Alexion $855m portfolio boost after Wilson Therapeutics buyout
April 11, 2018Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical
Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …
Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment
April 11, 2018Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
May announces £75m prostate cancer boost
April 10, 2018Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer
Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …
Keytruda scores big as a first-line monotherapy in NSCLC patients with any level of PD-L1 expression
April 10, 2018Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
Closely following the news that Keytruda (pembrolizumab) had failed in the treatment of unresectable or metastatic melanoma as a combination …
Media reports over Parkinson’s drug risk hit Acadia hard
April 10, 2018Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical
Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …
Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia
April 10, 2018Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma
A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …
Immunomedics’ whirlwind in the C-suite continues
April 10, 2018Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Looking to the future of oncology
April 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma
The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
